Literature DB >> 14977978

Susceptibility to tuberculosis: clues from studies with inbred and outbred New Zealand White rabbits.

Susan E Dorman1, Christine L Hatem, Sandeep Tyagi, Katherine Aird, Javier Lopez-Molina, M Louise M Pitt, Bernard C Zook, Arthur M Dannenberg, William R Bishai, Yukari C Manabe.   

Abstract

The rabbit model of tuberculosis (TB) is important because rabbits develop a disease that is similar to TB in humans, namely, granulomas with caseous necrosis, liquefaction, and cavities. We describe here a comparison of inbred and outbred New Zealand White rabbits infected by aerosol with either Mycobacterium tuberculosis Erdman or H37Rv strain. Five weeks after infection with either bacillary strain, the inbred rabbits had significantly larger pulmonary tubercles than did outbred rabbits (2.7 versus 1.4 mm in diameter; P < 0.01). After infection with H37Rv, the inbred rabbits had significantly more pulmonary tubercles than did the outbred rabbits (98 +/- 12 versus 33 +/- 13; P < 0.01), with more mycobacterial CFU per tubercle (809 +/- 210 versus 215 +/- 115; P = 0.027) (means +/- standard errors of the means). Compared with histologic examination of lung granulomas from outbred rabbits, histologic examination of those from inbred rabbits showed more caseous necrosis, more visible bacilli, and fewer mature epithelioid cells. The delayed-type hypersensitivity (DTH) responses to intradermal tuberculin were significantly lower, and peritoneal macrophages from uninfected inbred rabbits produced significantly less tumor necrosis factor alpha after lipopolysaccharide (LPS) stimulation in vitro than those from the outbred rabbits (2,413 +/- 1,154 versus 8,879 +/- 966 pg/ml). We conclude that these inbred rabbits were more susceptible to TB than their outbred counterparts and had an impaired ability to contain disease, resulting in more grossly visible tubercles that were larger than those observed in outbred rabbits. Preliminary evidence is presented for a cell-mediated immune defect with lower DTH responses and macrophages that have a decreased ability to respond to in vitro stimulation with LPS or M. tuberculosis infection.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14977978      PMCID: PMC356026          DOI: 10.1128/IAI.72.3.1700-1705.2004

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  29 in total

1.  Infliximab (chimeric anti-tumour necrosis factor alpha monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial. ATTRACT Study Group.

Authors:  R Maini; E W St Clair; F Breedveld; D Furst; J Kalden; M Weisman; J Smolen; P Emery; G Harriman; M Feldmann; P Lipsky
Journal:  Lancet       Date:  1999-12-04       Impact factor: 79.321

2.  Structural deficiencies in granuloma formation in TNF gene-targeted mice underlie the heightened susceptibility to aerosol Mycobacterium tuberculosis infection, which is not compensated for by lymphotoxin.

Authors:  A G Bean; D R Roach; H Briscoe; M P France; H Korner; J D Sedgwick; W J Britton
Journal:  J Immunol       Date:  1999-03-15       Impact factor: 5.422

3.  Human immunodeficiency virus-seronegative adults with extrapulmonary tuberculosis have abnormal innate immune responses.

Authors:  T R Sterling; S E Dorman; R E Chaisson; L Ding; J Hackman; K Moore; S M Holland
Journal:  Clin Infect Dis       Date:  2001-08-22       Impact factor: 9.079

4.  Genetic control of resistance to experimental infection with virulent Mycobacterium tuberculosis.

Authors:  I Kramnik; W F Dietrich; P Demant; B R Bloom
Journal:  Proc Natl Acad Sci U S A       Date:  2000-07-18       Impact factor: 11.205

5.  Association of vitamin D receptor genotypes with the susceptibility to pulmonary tuberculosis in female patients & resistance in female contacts.

Authors:  P Selvaraj; P R Narayanan; A M Reetha
Journal:  Indian J Med Res       Date:  2000-05       Impact factor: 2.375

6.  Immunopathologic effects of tumor necrosis factor alpha in murine mycobacterial infection are dose dependent.

Authors:  L G Bekker; A L Moreira; A Bergtold; S Freeman; B Ryffel; G Kaplan
Journal:  Infect Immun       Date:  2000-12       Impact factor: 3.441

7.  Association of functional mutant homozygotes of the mannose binding protein gene with susceptibility to pulmonary tuberculosis in India.

Authors:  P Selvaraj; P R Narayanan; A M Reetha
Journal:  Tuber Lung Dis       Date:  1999

8.  Effects of tumor necrosis factor alpha on host immune response in chronic persistent tuberculosis: possible role for limiting pathology.

Authors:  V P Mohan; C A Scanga; K Yu; H M Scott; K E Tanaka; E Tsang; M M Tsai; J L Flynn; J Chan
Journal:  Infect Immun       Date:  2001-03       Impact factor: 3.441

9.  Tumor necrosis factor alpha is a determinant of pathogenesis and disease progression in mycobacterial infection in the central nervous system.

Authors:  L Tsenova; A Bergtold; V H Freedman; R A Young; G Kaplan
Journal:  Proc Natl Acad Sci U S A       Date:  1999-05-11       Impact factor: 11.205

10.  Influence of polymorphism in the genes for the interleukin (IL)-1 receptor antagonist and IL-1beta on tuberculosis.

Authors:  R J Wilkinson; P Patel; M Llewelyn; C S Hirsch; G Pasvol; G Snounou; R N Davidson; Z Toossi
Journal:  J Exp Med       Date:  1999-06-21       Impact factor: 14.307

View more
  15 in total

Review 1.  Immunology of Mycobacterium tuberculosis Infections.

Authors:  Jonathan Kevin Sia; Jyothi Rengarajan
Journal:  Microbiol Spectr       Date:  2019-07

Review 2.  An overview of the lagomorph immune system and its genetic diversity.

Authors:  Ana Pinheiro; Fabiana Neves; Ana Lemos de Matos; Joana Abrantes; Wessel van der Loo; Rose Mage; Pedro José Esteves
Journal:  Immunogenetics       Date:  2015-09-23       Impact factor: 2.846

Review 3.  Latent tuberculosis infection: myths, models, and molecular mechanisms.

Authors:  Noton K Dutta; Petros C Karakousis
Journal:  Microbiol Mol Biol Rev       Date:  2014-09       Impact factor: 11.056

4.  Comparative analysis of genome sequences of the Th2 cytokine region of rabbit (Oryctolagus cuniculus) with those of nine different species.

Authors:  E Michael Gertz; Richa Agarwala; Rose G Mage; Alejandro A Schäffer
Journal:  Immunol Immunogenet Insights       Date:  2011-06-12

5.  Tuberculosis, pulmonary cavitation, and matrix metalloproteinases.

Authors:  Catherine W M Ong; Paul T Elkington; Jon S Friedland
Journal:  Am J Respir Crit Care Med       Date:  2014-07-01       Impact factor: 21.405

6.  Susceptibility to tuberculosis: composition of tuberculous granulomas in Thorbecke and outbred New Zealand White rabbits.

Authors:  Susana Mendez; Christine L Hatem; Anup K Kesavan; Javier Lopez-Molina; M Louise M Pitt; Arthur M Dannenberg; Yukari C Manabe
Journal:  Vet Immunol Immunopathol       Date:  2007-11-17       Impact factor: 2.046

7.  Establishment of a cottontail rabbit papillomavirus/HLA-A2.1 transgenic rabbit model.

Authors:  Jiafen Hu; Xuwen Peng; Lynn R Budgeon; Nancy M Cladel; Karla K Balogh; Neil D Christensen
Journal:  J Virol       Date:  2007-04-25       Impact factor: 5.103

Review 8.  Mycobacterium tuberculosis, macrophages, and the innate immune response: does common variation matter?

Authors:  William R Berrington; Thomas R Hawn
Journal:  Immunol Rev       Date:  2007-10       Impact factor: 12.988

9.  The aerosol rabbit model of TB latency, reactivation and immune reconstitution inflammatory syndrome.

Authors:  Yukari C Manabe; Anup K Kesavan; Javier Lopez-Molina; Christine L Hatem; Megan Brooks; Ricardo Fujiwara; Karl Hochstein; M Louise M Pitt; Joann Tufariello; John Chan; David N McMurray; William R Bishai; Arthur M Dannenberg; Susana Mendez
Journal:  Tuberculosis (Edinb)       Date:  2007-12-18       Impact factor: 3.131

10.  Accuracy and coverage assessment of Oryctolagus cuniculus (rabbit) genes encoding immunoglobulins in the whole genome sequence assembly (OryCun2.0) and localization of the IGH locus to chromosome 20.

Authors:  E Michael Gertz; Alejandro A Schäffer; Richa Agarwala; Amélie Bonnet-Garnier; Claire Rogel-Gaillard; Hélène Hayes; Rose G Mage
Journal:  Immunogenetics       Date:  2013-08-08       Impact factor: 2.846

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.